These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 31286354)

  • 1. Pravastatin and Simvastatin Pretreatment in Combination with Pyrimethamine and Sulfadiazine Reduces Infection Process of Toxoplasma gondii Tachyzoites (RH Strain) in HeLa Cells.
    Sanfelice RADS; da Silva SS; Bosqui LR; Machado LF; Miranda-Sapla MM; Panagio LA; Navarro IT; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
    Acta Parasitol; 2019 Sep; 64(3):612-616. PubMed ID: 31286354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pravastatin and simvastatin inhibit the adhesion, replication and proliferation of Toxoplasma gondii (RH strain) in HeLa cells.
    Sanfelice RA; da Silva SS; Bosqui LR; Miranda-Sapla MM; Barbosa BF; Silva RJ; Ferro EAV; Panagio LA; Navarro IT; Bordignon J; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
    Acta Trop; 2017 Mar; 167():208-215. PubMed ID: 28012901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of rosuvastatin in tachyzoites of Toxoplasma gondii (RH strain) in HeLa cells.
    Sanfelice RA; Machado LF; Bosqui LR; Miranda-Sapla MM; Tomiotto-Pellissier F; de Alcântara Dalevedo G; Ioris D; Reis GF; Panagio LA; Navarro IT; Bordignon J; Conchon-Costa I; Pavanelli WR; Almeida RS; Costa IN
    Exp Parasitol; 2017 Oct; 181():75-81. PubMed ID: 28774497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.
    Portes JA; De Souza W
    Parasitol Res; 2019 Dec; 118(12):3479-3489. PubMed ID: 31728720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
    Martins-Duarte ÉS; de Souza W; Vommaro RC
    Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
    Romand S; Pudney M; Derouin F
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of sulfadiazine and pyrimetamine for treatment of experimental toxoplasmosis with strains obtained from human cases of congenital disease in Brazil.
    Silva LA; Fernandes MD; Machado AS; Reis-Cunha JL; Bartholomeu DC; Almeida Vitor RW
    Exp Parasitol; 2019 Jul; 202():7-14. PubMed ID: 31077733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
    Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM
    Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone.
    Meneceur P; Bouldouyre MA; Aubert D; Villena I; Menotti J; Sauvage V; Garin JF; Derouin F
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1269-77. PubMed ID: 18212105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A.
    Mack DG; McLeod R
    Antimicrob Agents Chemother; 1984 Jul; 26(1):26-30. PubMed ID: 6383209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii.
    Khan AA; Lambert LH; Remington JS; Araujo FG
    Antimicrob Agents Chemother; 1999 Apr; 43(4):758-62. PubMed ID: 10103177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrofloxacin and Toltrazuril Are Able to Reduce
    da Silva RJ; Gomes AO; Franco PS; Pereira AS; Milian ICB; Ribeiro M; Fiorenzani P; Dos Santos MC; Mineo JR; da Silva NM; Ferro EAV; de Freitas Barbosa B
    Front Cell Infect Microbiol; 2017; 7():340. PubMed ID: 28798905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case-control study.
    Reiter-Owona I; Hlobil H; Enders M; Klarmann-Schulz U; Gruetzmacher B; Rilling V; Hoerauf A; Garweg JG
    Eur J Med Res; 2020 Nov; 25(1):59. PubMed ID: 33228795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-
    Teimouri A; Azami SJ; Keshavarz H; Esmaeili F; Alimi R; Mavi SA; Shojaee S
    Int J Nanomedicine; 2018; 13():1341-1351. PubMed ID: 29563791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxylamine and Carboxymethoxylamine Can Inhibit
    Li J; Guo H; Galon EM; Gao Y; Lee SH; Liu M; Li Y; Ji S; Jia H; Xuan X
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31907178
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis.
    Montazeri M; Emami S; Asgarian-Omran H; Azizi S; Sharif M; Sarvi S; Rezaei F; Sadeghi M; Gohardehi S; Daryani A
    Exp Parasitol; 2019 May; 200():7-12. PubMed ID: 30904693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azithromycin treatment is able to control the infection by two genotypes of Toxoplasma gondii in human trophoblast BeWo cells.
    Ribeiro M; Franco PS; Lopes-Maria JB; Angeloni MB; Barbosa BF; Gomes AO; Castro AS; Silva RJD; Oliveira FC; Milian ICB; Martins-Filho OA; Ietta F; Mineo JR; Ferro EAV
    Exp Parasitol; 2017 Oct; 181():111-118. PubMed ID: 28803905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of antiretroviral compounds against Toxoplasma gondii in vitro.
    Wang JL; Elsheikha HM; Li TT; He JJ; Bai MJ; Liang QL; Zhu XQ; Cong W
    Int J Antimicrob Agents; 2019 Dec; 54(6):814-819. PubMed ID: 31479744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo.
    Si H; Xu C; Zhang J; Zhang X; Li B; Zhou X; Zhang J
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):238-245. PubMed ID: 29684680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
    Romand S; Bryskier A; Moutot M; Derouin F
    J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.